While I appreciate and understand the need for venture capitalists in certain areas, particularly in biotechnology, I am concerned that throwing open the door to all SBIR programs without any limit might unfairly disadvantage small conventional businesses.
Dahlkemper expresses concern about potential disadvantages for small businesses due to expanded venture capitalist eligibility.
Share
More from KATHLEEN A. DAHLKEMPER
SBIR facilitates high-risk, high-reward research that does--not only spurs innovation but also creates jobs.
I just want to quote from Business Week, April 8, 2010. This is a quote by Mark Zandi, chief economist at Moody's Economy.com. ``When you take it all together, the response to the recession was massive, unprecedented, and ultimately…
What we need is an ability to keep watch on critical materials, anticipate problems and create policies that head off rather than respond to a crisis.
As we look at our country and look where we have been and how we got to where we are not just today but in the 200-plus years, it's our ingenuity, it's our resourcefulness, and it's our strong work ethic that really has always propelled…
Other voices in this conversation
